LF
Ling Felce
University of Oxford
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · T-cell and B-cell Immunology · SARS-CoV-2 and COVID-19 Research · vaccines and immunoinformatics approaches
0000-0001-8534-1629
Employment
-
University of Oxford Computational Biologist2020 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease Save
- RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line [version 2; peer review: 2 approved, 1 approved with reservations] Save
- CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model Save
- RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line Save
- Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9. Save
- Target Identification Using Chemical Probes. Save
- Discovery of an MLLT1/3 YEATS Domain Chemical Probe Save
- N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Save
- FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. Save
- Recombinant viral vaccines for cancer. Save
- MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity. Save